Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenic | 24 | 2024 | 63 | 7.650 |
Why?
|
Environmental Exposure | 16 | 2024 | 462 | 3.760 |
Why?
|
Water Pollutants, Chemical | 9 | 2024 | 196 | 2.880 |
Why?
|
Uranium | 6 | 2024 | 9 | 2.110 |
Why?
|
Lung Diseases | 4 | 2022 | 739 | 1.650 |
Why?
|
Atherosclerosis | 7 | 2024 | 402 | 1.540 |
Why?
|
Oryza | 3 | 2020 | 31 | 1.490 |
Why?
|
Cadmium | 6 | 2024 | 67 | 1.420 |
Why?
|
Selenium | 3 | 2024 | 36 | 1.250 |
Why?
|
Drinking Water | 6 | 2024 | 76 | 1.210 |
Why?
|
Nutrition Surveys | 5 | 2024 | 260 | 1.120 |
Why?
|
Mercury | 2 | 2023 | 40 | 1.020 |
Why?
|
Metals | 3 | 2024 | 123 | 0.990 |
Why?
|
Volatile Organic Compounds | 1 | 2024 | 57 | 0.880 |
Why?
|
Indians, North American | 3 | 2024 | 600 | 0.820 |
Why?
|
Extracellular Vesicles | 1 | 2024 | 129 | 0.780 |
Why?
|
Lung Diseases, Obstructive | 2 | 2020 | 46 | 0.750 |
Why?
|
Dietary Exposure | 1 | 2020 | 5 | 0.710 |
Why?
|
Water Supply | 4 | 2024 | 74 | 0.700 |
Why?
|
Edible Grain | 1 | 2020 | 48 | 0.690 |
Why?
|
Blood Pressure | 3 | 2024 | 1736 | 0.690 |
Why?
|
Forced Expiratory Volume | 5 | 2024 | 510 | 0.680 |
Why?
|
School Teachers | 3 | 2024 | 20 | 0.680 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 2003 | 0.640 |
Why?
|
California | 4 | 2024 | 400 | 0.610 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 679 | 0.580 |
Why?
|
Hypertension | 2 | 2024 | 1242 | 0.580 |
Why?
|
MicroRNAs | 1 | 2024 | 676 | 0.570 |
Why?
|
Middle Aged | 20 | 2024 | 31090 | 0.550 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 983 | 0.520 |
Why?
|
Cannabis | 1 | 2023 | 463 | 0.520 |
Why?
|
Female | 30 | 2024 | 68551 | 0.500 |
Why?
|
Longitudinal Studies | 6 | 2024 | 2715 | 0.470 |
Why?
|
Water Purification | 2 | 2016 | 148 | 0.470 |
Why?
|
Aged | 14 | 2024 | 22032 | 0.450 |
Why?
|
Humans | 41 | 2024 | 129266 | 0.440 |
Why?
|
Zinc | 4 | 2024 | 285 | 0.440 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 610 | 0.410 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 1000 | 0.410 |
Why?
|
Adult | 16 | 2024 | 35495 | 0.390 |
Why?
|
Male | 23 | 2024 | 63512 | 0.380 |
Why?
|
Bangladesh | 5 | 2019 | 42 | 0.380 |
Why?
|
Respiratory Tract Infections | 1 | 2016 | 375 | 0.370 |
Why?
|
Risk Factors | 8 | 2024 | 9745 | 0.360 |
Why?
|
Environmental Monitoring | 5 | 2024 | 306 | 0.360 |
Why?
|
United States | 11 | 2024 | 13826 | 0.360 |
Why?
|
Spirometry | 3 | 2021 | 257 | 0.360 |
Why?
|
Public Health | 3 | 2024 | 484 | 0.350 |
Why?
|
Cobalt | 3 | 2024 | 50 | 0.340 |
Why?
|
DNA Methylation | 3 | 2024 | 610 | 0.330 |
Why?
|
Cohort Studies | 4 | 2024 | 5409 | 0.330 |
Why?
|
Biomarkers | 6 | 2024 | 3968 | 0.330 |
Why?
|
Vital Capacity | 3 | 2020 | 291 | 0.330 |
Why?
|
Prospective Studies | 9 | 2024 | 7123 | 0.320 |
Why?
|
Respiration Disorders | 2 | 2020 | 72 | 0.310 |
Why?
|
Breast Neoplasms | 1 | 2021 | 2140 | 0.310 |
Why?
|
Lead | 3 | 2024 | 56 | 0.310 |
Why?
|
Manganese | 3 | 2024 | 59 | 0.310 |
Why?
|
Aged, 80 and over | 5 | 2024 | 7055 | 0.290 |
Why?
|
Tungsten | 2 | 2024 | 30 | 0.290 |
Why?
|
Copper | 2 | 2024 | 108 | 0.270 |
Why?
|
Lung | 4 | 2022 | 3927 | 0.270 |
Why?
|
Nickel | 2 | 2024 | 54 | 0.260 |
Why?
|
Neoplasms | 1 | 2020 | 2449 | 0.250 |
Why?
|
Respiratory Function Tests | 2 | 2019 | 583 | 0.250 |
Why?
|
Butadienes | 1 | 2024 | 36 | 0.230 |
Why?
|
Cities | 1 | 2024 | 105 | 0.220 |
Why?
|
Trees | 1 | 2024 | 69 | 0.220 |
Why?
|
Arsenicals | 2 | 2021 | 32 | 0.220 |
Why?
|
Barium | 1 | 2023 | 28 | 0.210 |
Why?
|
Tobacco Products | 1 | 2024 | 110 | 0.210 |
Why?
|
Tin | 1 | 2023 | 9 | 0.210 |
Why?
|
Trace Elements | 1 | 2024 | 49 | 0.210 |
Why?
|
Vascular Calcification | 1 | 2024 | 107 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 235 | 0.200 |
Why?
|
Bayes Theorem | 2 | 2021 | 373 | 0.200 |
Why?
|
Diet | 2 | 2020 | 1212 | 0.190 |
Why?
|
Repressor Proteins | 1 | 2024 | 406 | 0.180 |
Why?
|
Residence Characteristics | 1 | 2024 | 327 | 0.180 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 5050 | 0.160 |
Why?
|
Vaping | 1 | 2020 | 54 | 0.160 |
Why?
|
Environmental Pollutants | 1 | 2021 | 143 | 0.160 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 35 | 0.160 |
Why?
|
Disease Progression | 2 | 2024 | 2630 | 0.160 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2020 | 89 | 0.160 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2022 | 260 | 0.150 |
Why?
|
Coronary Disease | 1 | 2021 | 385 | 0.150 |
Why?
|
Sulfones | 1 | 2019 | 108 | 0.150 |
Why?
|
Metabolome | 1 | 2021 | 338 | 0.150 |
Why?
|
Prevalence | 1 | 2024 | 2553 | 0.140 |
Why?
|
Incidence | 2 | 2024 | 2636 | 0.140 |
Why?
|
Eating | 1 | 2020 | 368 | 0.140 |
Why?
|
Tuberculosis | 1 | 2020 | 273 | 0.130 |
Why?
|
Maternal Exposure | 1 | 2018 | 177 | 0.130 |
Why?
|
Pyrimidines | 1 | 2019 | 459 | 0.120 |
Why?
|
Carbon Monoxide | 1 | 2015 | 68 | 0.120 |
Why?
|
Memory, Short-Term | 1 | 2018 | 263 | 0.120 |
Why?
|
Creatine | 1 | 2015 | 58 | 0.120 |
Why?
|
Inhalation Exposure | 1 | 2015 | 91 | 0.120 |
Why?
|
Family Characteristics | 1 | 2016 | 178 | 0.110 |
Why?
|
Epidemiologic Studies | 2 | 2024 | 65 | 0.110 |
Why?
|
Surveys and Questionnaires | 2 | 2024 | 5384 | 0.110 |
Why?
|
Folic Acid | 1 | 2015 | 184 | 0.110 |
Why?
|
Air Pollution, Indoor | 1 | 2015 | 140 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 890 | 0.100 |
Why?
|
Young Adult | 2 | 2018 | 12391 | 0.090 |
Why?
|
Pregnancy | 1 | 2023 | 6390 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 1049 | 0.090 |
Why?
|
Cognition | 1 | 2018 | 1122 | 0.090 |
Why?
|
Sex Factors | 1 | 2016 | 1965 | 0.080 |
Why?
|
Water | 2 | 2023 | 441 | 0.080 |
Why?
|
Age Factors | 1 | 2016 | 3140 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2019 | 2342 | 0.060 |
Why?
|
Ethiopia | 1 | 2024 | 35 | 0.060 |
Why?
|
Smoking | 2 | 2024 | 1499 | 0.060 |
Why?
|
Kenya | 1 | 2024 | 107 | 0.060 |
Why?
|
New York City | 1 | 2024 | 80 | 0.060 |
Why?
|
Molybdenum | 1 | 2024 | 9 | 0.060 |
Why?
|
Forests | 1 | 2024 | 58 | 0.060 |
Why?
|
Nitrates | 1 | 2024 | 88 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2024 | 580 | 0.050 |
Why?
|
Apolipoproteins E | 1 | 2022 | 77 | 0.050 |
Why?
|
Environmental Pollution | 1 | 2021 | 18 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2024 | 433 | 0.050 |
Why?
|
Cacodylic Acid | 1 | 2021 | 2 | 0.050 |
Why?
|
Research | 1 | 2024 | 416 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2024 | 713 | 0.040 |
Why?
|
Observational Studies as Topic | 1 | 2020 | 110 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 279 | 0.040 |
Why?
|
Colony Count, Microbial | 1 | 1999 | 117 | 0.040 |
Why?
|
Rifampin | 1 | 1999 | 85 | 0.040 |
Why?
|
Wechsler Scales | 1 | 2018 | 53 | 0.040 |
Why?
|
United States Environmental Protection Agency | 1 | 2017 | 23 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 1999 | 350 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 1999 | 200 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 785 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 1999 | 309 | 0.030 |
Why?
|
Breath Tests | 1 | 2015 | 91 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2019 | 1290 | 0.030 |
Why?
|
Logistic Models | 1 | 2020 | 1985 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 230 | 0.030 |
Why?
|
Creatinine | 1 | 2015 | 491 | 0.030 |
Why?
|
Mothers | 1 | 2018 | 730 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 867 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2015 | 534 | 0.020 |
Why?
|
Adolescent | 2 | 2019 | 20313 | 0.020 |
Why?
|
Mice | 1 | 2022 | 16915 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 10459 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 10202 | 0.010 |
Why?
|
Animals | 1 | 2022 | 35309 | 0.010 |
Why?
|
Child | 1 | 2019 | 20785 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 1999 | 69 | 0.010 |
Why?
|
Quality Control | 1 | 1999 | 163 | 0.010 |
Why?
|
Culture Media | 1 | 1999 | 160 | 0.010 |
Why?
|
Mutation | 1 | 1999 | 3710 | 0.000 |
Why?
|